Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| Yudhistiara B et al. | 2019 | intact cell/cell culture, TK6 cells (lymphoblastoma cells) | static magnetic field, also other exposures without EMF, co-exposure | - |
| Zafari J et al. | 2024 | intact cell/cell culture, A2780 (human ovarian carcinoma-sensitive to cisplatin) and A2780-CP (human ovarian carcinoma-resistant to cisplatin) | static magnetic field, also other exposures without EMF, co-exposure | - |
| Sarvestani AS et al. | 2010 | intact cell/cell culture, bone marrow stem cells (rat) | static magnetic field, co-exposure, also other exposures without EMF | - |
| Wang S et al. | 2022 | intact cell/cell culture, MNNG/HOS, U-2 OS and MG63 (human osteosarcoma cell lines) | static magnetic field, co-exposure, also other exposures without EMF | - |
| Martino CF et al. | 2010 | intact cell/cell culture, HCT116 cells (colorectal cancer cells) and HT1080 cells (human fibrosarcoma cell line) | static magnetic field, geomagnetic field, shielding/field deprivation | 500 nT–45 µT |
| Alipour M et al. | 2022 | intact cell/cell culture, rat bone marrow-derived mesenchymal cells (BMSCs) | static magnetic field, magnetic field, 50/60 Hz, co-exposure | - |
| Schwenzer NF et al. | 2007 | intact cell/cell culture, Hel 299 (human fibroblast cell line) | static magnetic field, magnetic field, MRI | - |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
